POET Technologies, a leader in optical computing for AI infrastructure, trades at $9.40, well below its 52-week high but with a strong buy rating and a price target of $21.14, implying 125% upside. The company showed 112% revenue growth year-over-year but missed expectations slightly, while maintaining a strong cash position after a $400 million offering. Bulls are optimistic due to a $50 million initial order from Lumilens and plans to ship over 30,000 optical engines in 2026, tapping into a rapidly growing $26 billion AI cluster Ethernet optics market. Risks include high valuation, past revenue misses, and execution challenges, but successful scaling and production ramp could drive significant stock gains.
Target reported stronger-than-expected Q2 results with sales up 5.3% to $26.54 billion and adjusted EPS rising 20% excluding tariff refunds. Digital sales grew 8.7%, driven by same-day delivery, and all core merchandise categories saw sales increases...
ReElement Technologies, partly owned by American Resources Corp, has obtained a Minor Source air permit for its Marion, Indiana Supersite, allowing all planned production lines to operate. This permit is a key step before the facility can begin equip...
Jefferies maintains a 'buy' rating on Diageo with a 2,200p price target, signaling about 30% upside from current levels. The latest annual report reveals a strategic shift from focusing on single brands like Guinness to a broader portfolio approach, ...
Acadia Healthcare (ACHC) is rated a BUY due to its robust capacity expansion pipeline and the increasing demand for mental health services in the US. As the largest independent behavioral healthcare provider with 279 facilities and 12,600 beds, ACHC ...
A survey of over 1,400 ear, nose, and throat (ENT) doctors reveals that 80% believe a proposed Medicare payment cut by CMS will limit seniors' access to care. The cut targets payments for same-day evaluations and procedures, potentially causing longe...
